Dipesh Mehta, Nirmal Bang Securities is of the view that one can buy Ranbaxy Laboratories.
Mehta told CNBC-TV18, "Buy Ranbaxy because, it has broken channel pattern and I think it will go around Rs 570 on the higher side and Rs 590 also in a month. Hence, with a small stoploss of Rs 530 on the lower side. I think it is a very good bet.”Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
